Newsfeeds Archive - Page 437 of 461

1 minute read

Analysts See Softened Timelines For CRISPR Therapeutics’ Sickle Cell Candidate In US

August 9, 3:26 PM

Barclays says that CRISPR Therapeutics AG’s (NASDAQ: CRSP) Q2 FY22 earnings release was largely incremental, highlighting the progress of multiple clinical programs, including the…

BLUE

1 minute read

Smiths Acquisition Weighs On ICU Medical’s Profitability, Shares Fall

By Vandana Singh

August 9, 3:15 PM

ICU Medical Inc (NASDAQ:ICUI) reported Q2 sales of $561 million, up 75% Y/Y, due to Smiths Medical’s acquisition, and missing…

ICUI

1 minute read

Atara Lays Off 20% Of Its Workforce, Issues Update On Cell Therapies

By Vandana Singh

August 9, 3:01 PM

Atara Biotherapeutics Inc (NASDAQ:ATRA) will reduce cash burn by laying off 20% of its staff and extend the cash…

ATRA

2 minute read

Amazon Receives FDA Warning Letter For OTC Mole Removal Products

By Vandana Singh

August 9, 2:38 PM

The FDA’s Center for Drug Evaluation and Research released a warning letter sent to Amazon Inc’s (NASDAQ:AMZN) CEO Andy Jassy for selling…

AMZN

1 minute read

Heron Shares Jump After Equity Financing, Q2 Earnings

By Vandana Singh

August 9, 2:10 PM

Heron Therapeutics Inc (NASDAQ:HRTX) reported Q2 sales of $27.63 million, +23.1% Y/Y, beating the consensus of $24.31 million. Oncology sales…

HRTX

1 minute read

Endo Shares Plunge On Imminent Bankruptcy Filing

By Vandana Singh

August 9, 1:38 PM

Endo International plc’s (NASDAQ:ENDP) Q2 sales decreased 20% to $569.11 million, beating the consensus of $529.94 million. The decrease was…

ENDP

1 minute read

Acadia Terminates Painkiller, Cancer Candidate After Disappointing Data

By Vandana Singh

August 9, 1:24 PM

Acadia Pharmaceuticals Inc (NASDAQ:ACAD) stopped working on two candidates, including a one-time competitor to Vertex Pharmaceuticals Incorporated’s (NASDAQ:VRTX) non-opioid painkiller. The company…

ACAD

1 minute read

Merck Re-enters Alzheimer’s R&D With Research Pact With Cerevance

By Vandana Singh

August 9, 1:21 PM

Cerevance, a private, clinical-stage drug discovery and development company, announced a multi-year strategic research collaboration with Merck & Co Inc (NYSE:MRK). The…

MRK

1 minute read

NeuroOne Medical Shares Fall After EEG Electrode Regulatory Update

By Vandana Singh

August 9, 1:16 PM

NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) has submitted a special 510(k) to the FDA for its sEEG electrode to extend the duration…

NMTC

1 minute read

FDA Pushes Decision Date For Reata’s Genetic Neuromuscular Disease Candidate

By Vandana Singh

August 9, 12:04 PM

The FDA has extended the review timeline for Reata Pharmaceuticals Inc’s (NASDAQ:RETA) marketing application seeking approval for omaveloxolone for Friedreich’s ataxia by…

RETA